|
TP53BP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.719000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.742000E-01 |
| Normal-vs-Stage2 |
9.996400E-01 |
| Normal-vs-Stage3 |
9.235800E-02 |
| Normal-vs-Stage4 |
1.916160E-01 |
| Stage1-vs-Stage2 |
6.834600E-01 |
| Stage1-vs-Stage3 |
1.393650E-02 |
| Stage1-vs-Stage4 |
3.887900E-02 |
| Stage2-vs-Stage3 |
1.594160E-01 |
| Stage2-vs-Stage4 |
2.645800E-01 |
| Stage3-vs-Stage4 |
7.823000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.153800E-01 |
| Normal-vs-AfricanAmerican |
3.733800E-01 |
| Normal-vs-Asian |
5.914400E-01 |
| Caucasian-vs-AfricanAmerican |
2.755000E-01 |
| Caucasian-vs-Asian |
3.556800E-01 |
| AfricanAmerican-vs-Asian |
6.882600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.615600E-01 |
| Normal-vs-Female |
8.932600E-01 |
| Male-vs-Female |
5.527800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.213000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.079600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.294200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.728420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.189400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.082430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.828800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.901400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.771600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.008800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.32480000003543E-06 |
| Classical-VS-Follicular |
3.653800E-01 |
| Classical-VS-Other |
2.063200E-01 |
| Classical-VS-Normal |
5.720800E-01 |
| Tall-VS-Follicular |
3.821500E-03 |
| Tall-VS-Other |
3.865600E-01 |
| Tall-VS-Normal |
6.017800E-04 |
| Follicular-VS-Other |
5.283800E-01 |
| Follicular-VS-Normal |
7.513400E-01 |
| Other-VS-Normal |
2.323400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.745200E-01 |
| Normal-vs-N1 |
1.873550E-01 |
| N0-vs-N1 |
2.593200E-01 |
|
|
